Anti-PCSK9 (RG7652) is a fully human monoclonal antibody of the immunoglobulin G1 (IgG1) subclass, designed to specifically target proprotein convertase subtilisin/kexin type 9 (PCSK9). This antibody has demonstrated potential efficacy in reducing the risk associated with coronary heart disease (CHD) by modulating lipid metabolism through the inhibition of PCSK9, a key regulator of cholesterol homeostasis. Anti-PCSK9 (RG7652) is suitable for use in research focused on lipid disorders, cardiovascular diseases, and the molecular mechanisms of cholesterol regulation.
Anti-PCSK9 (RG7652) is a fully human monoclonal antibody of the immunoglobulin G1 (IgG1) subclass, designed to specifically target proprotein convertase subtilisin/kexin type 9 (PCSK9). This antibody has demonstrated potential efficacy in reducing the risk associated with coronary heart disease (CHD) by modulating lipid metabolism through the inhibition of PCSK9, a key regulator of cholesterol homeostasis. Anti-PCSK9 (RG7652) is suitable for use in research focused on lipid disorders, cardiovascular diseases, and the molecular mechanisms of cholesterol regulation.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
